A 90-day Master Marketing Plan and Minimum Viable Platform for [Company Name], built around three revenue tracks: a referral network, direct buying and a private-label program. We plan and build at the same time, so every week produces a live asset, a tested hypothesis or a decision.
Proof is the product. Don't trust the label. Verify the batch.
See the three tracks 12-week planYou already have demand, strong margins and a reported ~$30 CAC. The constraint is the system around the customer.
The path to $1M a month does not come from one funnel. It comes from three engines that share one brand, one set of proof and one data stack. Each track gets its own page, its own audience and its own scorecard.
A “become a rep” page where qualified people sign up, get a link and code, and sell for you. Trainers, spas, wellness centers and creators.
The retail experience you have now, rebuilt so anyone can find a compound, verify the lot and buy in a few clicks.
An offer for gyms, clinics, creators and entrepreneurs to launch their own line. They bring the brand, you handle sourcing, testing, labeling and shipping.
Nine signals from the public footprint and your own account of the business. They are observations to validate in Weeks 1 and 2, not final findings. Each one either leaks revenue, raises risk or hands traffic to a competitor.
Signal: The logo says Axis Chems, the storefront and legal copy say Axis Peptides, and earlier search research surfaced a third identity, Axis Peptide Group, on another domain.
Why it matters: backlinks, reviews and search signals are divided, and buyers cannot tell which brand to trust.
Signal: Indexed copy has tied products to metabolism, tissue repair, inflammation and recovery. Wellness ads running next to research-only disclaimers send mixed signals about intended use.
Why it matters: a research-use-only label alone may not hold up against other content. More visibility magnifies the exposure. Claims language should be tightened first.
Signal: Accounts get taken down overnight, and two months without an issue is your longest run. Growth depends on a channel you do not control.
Why it matters: every shutdown resets learning, wastes creative and stalls revenue.
Signal: Tag Manager and a Facebook pixel are present, but nothing confirms GA4 ecommerce events, deduplication or SKU-level revenue. The $30 CAC is not tied to margin, repeat rate or LTV.
Why it matters: you cannot tell which dollar to scale, so scaling spend scales ambiguity.
Signal: Ads promote vitamins and wellness compounds, the homepage leads with them, and visitors who came for peptides bounce.
Why it matters: paid clicks are lost at the first screen and bounce rate rose when this ad approach started.
Signal: The homepage says “COA with every product” and, in another block, “quality documentation available on request.” Competitors show the lot result before checkout.
Why it matters: the strongest trust asset reads as a hurdle instead of proof.
Signal: In sampled searches the homepage surfaced, but individual product, category, COA and educational pages did not, while competitors rank with detailed specification pages.
Why it matters: competitors intercept high-intent searches before buyers ever meet Axis.
Signal: The only visible AOV lever is free shipping over $150. No subscription, tiered quantity pricing or reorder program shows on the storefront.
Why it matters: every sale is a new acquisition, which is the opposite of the economics a $1M month needs.
Signal: Peptides, nasal sprays and a hair serum sit under one “research grade” promise, and the vitamin ads sit outside it entirely.
Why it matters: a diluted proposition is harder to rank for, harder to advertise and harder to defend.
A mix of affiliates, direct orders and private-label partners reaches the goal with far less paid traffic than a single-channel plan. Move the sliders to see the mix and the budget. These are scenarios with placeholder inputs, and your real wholesale prices and order data replace them in Week 2.
Planning and building run side by side, and live assets ship from week one so the impact shows up out of the gate. Each phase ends at a decision gate, and ad spend is released in tranches only when the gate is met.
The minimum viable platform: the smallest set of assets that lets you measure, convert and retain customers properly.
Single brand and domain, with documented redirects, canonicals, sitemaps and indexation under control.
GA4, GTM and Search Console event architecture that ties source to SKU to purchase to reorder, with a weekly scorecard by Day 30.
A homepage and product template that match the ad promise, so peptide-intent visitors stop bouncing off a vitamin-first page.
Public, searchable lot documentation before checkout. Verification becomes the differentiator, not a footnote.
A 5 to 7 question product-finder that segments buyers by category, documentation needs and volume, with no dosing or human-use advice.
A qualification path that routes high-volume and recurring buyers to a human sales workflow.
Welcome, quiz, browse, cart, post-purchase, reorder, B2B and win-back flows driven by behavior.
Technical product pages, category hubs and COA records with unique specifications, built for quality over page count.
Verification-led video and static creative, plus search, social and remarketing tests that follow platform policies with CAC stop and scale thresholds.
“99% tested” is now table stakes. The suppliers pulling ahead make quality verifiable before the sale. The opening for Axis Chems is to make that proof the product: verify the exact lot before you order.
| Capability | Axis today | ExactAmino | American Peptides | PepTech |
|---|---|---|---|---|
| Lot-level documentation | Homepage says “on request” | Lot-by-lot emphasis | Lot-matched COAs | Results exposed |
| Identity testing (mass spec) | Not shown | Not confirmed | HPLC plus mass spec | HPLC plus LC-MS |
| Product page depth | Not surfacing in search | Not confirmed | Specs, lot, verification, FAQs | Specs and test data |
| Subscription pricing | None visible | Not confirmed | Up to 15% subscribe and save | Not confirmed |
| Volume pricing | None visible | Not confirmed | Automatic volume tiers | Not confirmed |
| Educational content | Thin | Not confirmed | COA education | Not confirmed |
Competitor findings come from public pages reviewed in our prior research. Some competitors also publish endotoxin results or QR-linked batch verification. Week 1 re-verifies every cell, and we never recommend claiming a test your lab has not performed.
You have lived the cost of ad accounts disappearing overnight. The answer is not more workarounds. It is owned audiences, compliant claims and diversified channels.
Most baselines are unknown today, and we will not invent them. Week 1 and 2 establish them, and the targets below are management gates.
| Metric | Today | Day-90 target |
|---|---|---|
| Blended CAC | ~$30 reported | Validate; investigate if sustained above $35 before scaling |
| AOV and gross margin by SKU | Unknown | Baselined by Week 2; bundle and volume tests live |
| Site conversion rate | Unknown | Baseline Week 2; +20% relative lift on priority funnels |
| Repeat rate and 30/60/90-day LTV | Unknown | Cohort model live by Week 9 |
| Quiz completion and opt-in | New | 50% of starts complete; 8% to 15% opt-in on qualified sessions (test targets) |
| Priority page indexation | Unknown | Above 90% of intentionally indexable URLs |
| Affiliate network | New | Approved affiliates, activation rate and monthly volume per affiliate tracked from launch |
| Private-label pipeline | New | Applications, calls booked, partners signed and first-order volume tracked separately |
Six client outcomes from six verticals, all built on the same infrastructure-first methodology proposed here.
“In the first year of our campaign, we have gone from $100,000/month to over $2,200,000/month in sales. $1M/month in sales growth in the last 3 months alone.”
After a previous agency cost them nearly all their Google rankings, Ezzey rebuilt everything: 9.2x revenue, 5.2x leads, 33% lower cost per lead in 24 months.
12,104 qualified leads over 8 months at an average $18.01 per lead, with conversion up and lead quality held while paid budget scaled.
Initial $4,000 ad spend generated $100,000 in revenue, with 8x ROAS across every campaign Ezzey has run.
Show-up rate up 100%, from 40% to 80%. 95% of negative content removed, with 77 negative properties suppressed and replaced.
An underperforming Google Ads account became a 3,519% revenue increase, doubling ad spend while finally hitting ROI targets.
“We get the added benefit of having a fully outsourced digital marketing department and killer results.”
“Michael and his team at Ezzey are true professionals. They explained everything in detail while catering to my needs to grow my business.”
“Professional, knowledgeable, and gets the job done. Cannot say enough about how much I appreciate what the team has done.”
“It was like we hired 5 different expert teams.”
“The Ezzey team understands what it takes to create a relevant brand that attracts the right audience.”
“Ezzey came in and found the customers we were missing. The ROI has been huge.”
Three stacked components so you pay for exactly the work that is running each month.
| Component | Month 1 | Month 2 | Month 3 | Total |
|---|---|---|---|---|
| MMP + MVP creation and execution | $12,500 | $12,500 | $12,500 | $37,500 |
| Infrastructure repair and optimization | $6,250 | $6,250 | $6,250 | $18,750 |
| Advertising execution and optimization | Not active | $4,250 | $4,250 | $8,500 |
| Partner programs build (affiliate network and private label) | $6,500 | $6,500 | $6,500 | $19,500 |
| Monthly total | $25,250 | $29,500 | $29,500 | $84,250 |
Ad spend, content production, development beyond scope, video, software, any legal review you choose to obtain and lab testing are separate and approved before they are incurred. EZZEY offers no performance guarantee on third-party platforms. After Day 90, a hybrid model with a revenue share on partner-network growth can replace part of the monthly fee.
To begin the foundation sprint we need access and a few documents.